Bioequivalence Study of Levothyroxine Sodium Tablets 100 mcg
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to establish the bioequivalence of two levothyroxine
formulations through the estimation of T4 levels in serum samples after baseline correction,
according to Food and Drugs Administration (FDA), World Health Organization (WHO) and
Colombian National Vigilance Institute for Drugs and Food (INVIMA) guidelines.